The N-methyl-D-aspartate (NMDA) receptor, a subtype of excitatory amino acid receptor, mediates synaptic responses in many regions of the central nervous system. This receptor plays a critical role in the mechanisms of both synaptic plasticity and excitotoxicity. Although these receptors were generally thought to be a single homogeneous receptor population, we report observations indicating that two anatomically distinct forms of the NMDA-receptor complex exist. buffer, pH 7.0, preincubated at 30°C for 10 min, and then incubated for 10 min in ice-cold buffer containing 100 nM L-[3H]glutamate. NMDA receptors were selectively labeled by the inclusion of 100 ,uM 4-acetamido-4'-isothiocyanoatostilbene-2,2'-disulfonic acid, 5 ,uM amino-3-hydroxy-5-methylisoxazole-4-propionic acid, and 1 ,M kainic acid, which displace all detectable non-NMDA-receptor binding. Under these conditions the specific binding is fully displaced by NMDA agonists and antagonists at concentrations appropriate for NMDA receptors (12) (13) (14) (15) (16) (17) (18) .
[3H]glutamate, [3H]CPP binding is low in the striatum and septum and high in the thalamus and inner cerebral cortex. (it) NMDA antagonists are relatively more potent than agonists at displacing L-[3H]glutamate binding in the thalamus and cerebral cortex; agonists are relatively more potent in the striatum and cerebellum. (iiW) Glycine, which potentiates NMDAreceptor responses to glutamate, causes a greater percentage increase in L-[3H]glutamate binding to NMDA, receptors in the thalamus and cerebral cortex than in the striatum, septum, and cerebellum. Radiolabeled NMDA-antagonist binding, in contrast, is inhibited by glycine. Thus, as observed for yaminobutyric acid type A receptors, NMDA receptors have an agonist-preferring binding-site population and an antagonistpreferring binding site population. These may represent two distinct receptors and/or two interconverting forms. It could be of significant clinical importance if these two sites differ in their response to NMDA.
N-methyl-D-aspartate (NMDA) receptors mediate a potent excitatory response in many brain regions. Studies with selective NMDA antagonists have shown that this receptor appears capable of initiating certain forms of experiencedependent synaptic plasticity. Excessive NMDA receptor activation, such as that which occurs during seizures, ischemia, and hypoglycemia, results in cell death (1) (2) (3) (4) (5) (6) (7) . Consequently, identification of multiple populations of NMDA receptors would be important for understanding basic mechanisms of synaptic function and clinical pharmacology. Structure-activity studies of the NMDA-receptor complex generally indicate that the NMDA-receptor population is homogeneous. However, some observations suggest heterogeneity (8) (9) (10) .
Given that multiple populations of NMDA receptors are not likely to have identical distributions, we tested for possible receptor (12) (13) (14) (15) (16) (17) (18) .
Sections were then rinsed for 30 s, air dried, and placed against tritium-sensitive film along with tritium standards. Tissue sections in the experiments described in Fig. 2 were incubated for 20 min followed by a 20-s rinse.
[3H]CPP autoradiography was done as described (19 For further analysis, the data were pooled into agonists and antagonists groups (Fig. 2B) . These values were then expressed relative to binding obtained in the absence of added drugs by dividing the normalized binding value in the presence of a drug by the normalized binding value obtained in the absence of drug (this value is further described in the figure legend). This analysis reveals that both agonists and antagonists exhibit a regional variation in their potency as inhibitors of L-[3H]glutamate binding and that the cerebellum and striatum are significantly (P < 0.005) more sensitive to agonists, whereas the thalamus and cortex are significantly more sensitive to antagonists. Thus, although L-[3H]glutamate predominately labels an agonist-preferring population, some of its binding appears to be to an antagonist-preferring population.
Interestingly, cerebellar NMDA receptors, which are unique in their low affinity for thienylphencyclidine at the NMDA ion channel (22) , are also anomalous in being relatively insensitive to both agonists and antagonists (Fig. 2) 
DISCUSSION
We obtained three lines of evidence indicating that NMDA radioligands bind to at least two anatomically distinct populations of binding sites, which we term agonist-preferring and antagonist-preferring. ( (9, 12-22, 24, 25) . Some of the quantitative differences between agonist and antagonist binding could correspond to differences between one of the multiple points of agonist-and antagonist-receptor attachment, as we and others have suggested (26, 27 (10, 34) and has been suggested to be occurring in Huntington disease (35, 36) . The hypothesis of a receptor form exhibiting greater responsiveness could also account for observations of altered NMDA receptor activity occurring in development (37) and following kindling (38) . Thus, resolution of these issues may have significant implications for the role of NMDA receptors in development, learning, and pathology.
